MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517092157 A) filed by Merck Sharp & Dohme Llc; and Merck Sharp & Dohme (UK) Limited, Rahway, U.S.A., on Sept. 25, for 'controlled release pde10a formulations.'
Inventor(s) include Dinunzio, James C.; Harris, David; Kumar, Maria Sharlini; Pollitt, Michael John; Radojevic, Jovana; and Terife, Graciela.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates generally to treatment of central nervous system disorders associated with phosphodiesterase 10A (PDE10A) such as schizophrenia, bipolar disease, and Alzheimer's disea...